TrialVascular health and risk management2012

Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers.

Elaine Chiquette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.